Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans

Diabetes. 1997 Aug;46(8):1328-35. doi: 10.2337/diab.46.8.1328.

Abstract

The aim of the study was to determine the effects of specific levels of antecedent hypoglycemia on subsequent autonomic, neuroendocrine, and metabolic counterregulatory responses. Eight healthy, overnight-fasted male subjects were studied during 2-day protocols on four separate randomized occasions separated by at least 2 months. On day 1, insulin was infused at a rate of 9 pmol x kg(-1) x min(-1) and 2-h clamped euglycemia (plasma glucose 5.2 +/- 0.2 mmol/l) or differing hypoglycemia (plasma glucose 3.9 +/- 0.1, 3.3 +/- 0.1, or 2.9 +/- 0.1 mmol/l) was obtained during morning and afternoon. The next morning after an evening meal and 10-h overnight fast, each subject underwent a 2-h hyperinsulinemic (9 pmol x kg(-1) x min[-1]) hypoglycemic (2.9 +/- 0.1 mmol/l) clamp study. Despite equivalent day 2 plasma glucose and insulin levels, differing levels of antecedent hypoglycemia produced specific blunting of subsequent counterregulatory responses. Day 1 hypoglycemia of 3.9 mmol/l resulted in significantly (P < 0.01) blunted epinephrine, muscle sympathetic nerve activity, and glucagon responses. Day 1 hypoglycemia of 3.3 mmol/l resulted in additional significant blunting (P < 0.01) of pancreatic polypeptide, norepinephrine, growth hormone, endogenous glucose production, and lipolytic responses. Deeper day 1 hypoglycemia of 2.9 mmol/l produced similar day 2 counterregulatory failure as day 1 hypoglycemia of 3.3 mmol/l. In summary, in healthy overnight-fasted men, mild antecedent hypoglycemia of 3.9 mmol/l significantly blunts sympathoadrenal and glucagon, but not other forms of neuroendocrine counterregulatory responses, to subsequent hypoglycemia. Antecedent hypoglycemia of 3.3 mmol/l resulted in additional significant blunting of all major neuroendocrine and metabolic responses to subsequent hypoglycemia. We conclude that in normal humans, there is a hierarchy of blunted counterregulatory responses that are determined by the depth of antecedent hypoglycemia.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Blood Glucose / analysis
  • Blood Glucose / metabolism
  • Dose-Response Relationship, Drug
  • Epinephrine / blood
  • Glucagon / blood
  • Glucose / metabolism
  • Glucose Clamp Technique
  • Human Growth Hormone / blood
  • Humans
  • Hydrocortisone / blood
  • Hyperglycemia / blood*
  • Hyperglycemia / physiopathology
  • Hypoglycemia / blood*
  • Hypoglycemia / physiopathology
  • Insulin / administration & dosage
  • Insulin / blood
  • Male
  • Neurosecretory Systems / metabolism*
  • Norepinephrine / blood
  • Pancreatic Polypeptide / blood
  • Single-Blind Method
  • Time Factors

Substances

  • Blood Glucose
  • Insulin
  • Human Growth Hormone
  • Pancreatic Polypeptide
  • Glucagon
  • Glucose
  • Hydrocortisone
  • Norepinephrine
  • Epinephrine